HSA — authorised 2 July 2020
- Marketing authorisation holder: ViiV Healthcare Company
- Status: likely_approved
HSA authorised Rukobia on 2 July 2020
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 2 July 2020.
ViiV Healthcare Company holds the Singaporean marketing authorisation.